135 related articles for article (PubMed ID: 25595243)
1. Optimizing the leveraging of real-world data to improve the development and use of medicines.
Berger ML; Lipset C; Gutteridge A; Axelsen K; Subedi P; Madigan D
Value Health; 2015 Jan; 18(1):127-30. PubMed ID: 25595243
[TBL] [Abstract][Full Text] [Related]
2. Big data, advanced analytics and the future of comparative effectiveness research.
Berger ML; Doban V
J Comp Eff Res; 2014 Mar; 3(2):167-76. PubMed ID: 24645690
[TBL] [Abstract][Full Text] [Related]
3. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
Mullins CD; Sanchez RJ
J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
[TBL] [Abstract][Full Text] [Related]
4. Assessing the value of patient-generated data to comparative effectiveness research.
Howie L; Hirsch B; Locklear T; Abernethy AP
Health Aff (Millwood); 2014 Jul; 33(7):1220-8. PubMed ID: 25006149
[TBL] [Abstract][Full Text] [Related]
5. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
[TBL] [Abstract][Full Text] [Related]
6. Interview: access to richer data promises to usher in a new era of insight into patient heterogeneity.
Berger ML
J Comp Eff Res; 2013 Mar; 2(2):109-12. PubMed ID: 24236552
[No Abstract] [Full Text] [Related]
7. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
8. Matching study designs to disability-related comparative effectiveness research questions.
Ballou J; Rich E; Kehn M
J Comp Eff Res; 2013 Jan; 2(1):59-68. PubMed ID: 24236522
[TBL] [Abstract][Full Text] [Related]
9. Optimizing health information technology's role in enabling comparative effectiveness research.
Navathe AS; Conway PH
Am J Manag Care; 2010 Dec; 16(12 Suppl HIT):SP44-7. PubMed ID: 21314220
[TBL] [Abstract][Full Text] [Related]
10. Importance of health information technology, electronic health records, and continuously aggregating data to comparative effectiveness research and learning health care.
Miriovsky BJ; Shulman LN; Abernethy AP
J Clin Oncol; 2012 Dec; 30(34):4243-8. PubMed ID: 23071233
[TBL] [Abstract][Full Text] [Related]
11. Reengineering acute episodic and chronic care delivery: the Geisinger Health System experience.
Slotkin JR; Casale AS; Steele GD; Toms SA
Neurosurg Focus; 2012 Jul; 33(1):E16. PubMed ID: 22746233
[TBL] [Abstract][Full Text] [Related]
12. From comparative effectiveness research to patient-centered outcomes research: policy history and future directions.
D'Arcy LP; Rich EC
Neurosurg Focus; 2012 Jul; 33(1):E7. PubMed ID: 22746239
[TBL] [Abstract][Full Text] [Related]
13. Family pediatrics: report of the Task Force on the Family.
Schor EL;
Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
[TBL] [Abstract][Full Text] [Related]
14. Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making.
Berger ML; Sox H; Willke RJ; Brixner DL; Eichler HG; Goettsch W; Madigan D; Makady A; Schneeweiss S; Tarricone R; Wang SV; Watkins J; Mullins CD
Value Health; 2017 Sep; 20(8):1003-1008. PubMed ID: 28964430
[TBL] [Abstract][Full Text] [Related]
15. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
16. The role of public health surveillance: information for effective action in public health.
Wetterhall SF; Pappaioanou M; Thacker SB; Eaker E; Churchill RE;
MMWR Morb Mortal Wkly Rep; 1992 Dec; 41 Suppl():207-18. PubMed ID: 1344260
[TBL] [Abstract][Full Text] [Related]
17. Beyond coverage and supply: measuring access to healthcare in today's market.
Gold M
Health Serv Res; 1998 Aug; 33(3 Pt 2):625-52; discussion 681-4. PubMed ID: 9685110
[TBL] [Abstract][Full Text] [Related]
18. Exploring opportunities for collaboration between the corporate sector and the dental education community.
Alexander D; Clarkson J; Buchanan R; Chadwick G; Chesters R; Drisko CL; Douglass CW; Farrell L; Fletcher K; Makoni F; Monaco M; Nordquist B; Park NI; Riggs S; Schou L; Smales FC; Stamm JW; Toh CG; Volpe T; Ward P; Warren P
Eur J Dent Educ; 2008 Feb; 12 Suppl 1():64-73. PubMed ID: 18289269
[TBL] [Abstract][Full Text] [Related]
19. Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policy.
Lipworth W; Doran E; Kerridge I; Day R
Aust Health Rev; 2014 May; 38(2):160-8. PubMed ID: 24589424
[TBL] [Abstract][Full Text] [Related]
20. The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy.
Ahmed S; Berzon RA; Revicki DA; Lenderking WR; Moinpour CM; Basch E; Reeve BB; Wu AW;
Med Care; 2012 Dec; 50(12):1060-70. PubMed ID: 22922434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
